Live CME Offerings

Our live CME events cover a wide range of activities, including regularly scheduled Columbia University Irving Medical Center (CUIMC) departmental Grand Rounds as well as campus-based and off-site accredited educational symposia. We offer CME courses for board review, clinical and scientific updates in a broad range of medical fields, presentation of new discoveries or applications to improve health and disease prevention, and hands-on workshops for medical and scientific technologic advances and improvements in patient safety and care.

E.g., 04/16/2021

  • WEBINAR: GU Cancer

    Thursday, April 22, 2021
    5:00 PM to 6:30 PM
    ZOOM
    • College of Physicians and Surgeons
    Challenges in Management of Bladder and Prostate Cancer in 2021: What Happens When the Standard of Care is Not Enough?  This symposium will focus on updating practitioners on recent developments in the management of high risk localized prostate cancer, BCG unresponsive nonmusclei invasive bladder cancer as well as the multidisciplinary management of muscle invasive bladder cancer. These updates will include descriptions of the epidemiology of these entities as well as recently published data describing innovative ways of managing these three clinical disease states. A particular focus will be placed on ongoing clinical trials available at Columbia University’s Herbert Irving Cancer Center. The target audience of this seminar will include practicing Urologists, medical oncologists, radiation oncologists, nurse practitioners, and trainees interested in prostate and bladder cancer care. Upon conclusion of this activity, participants will be better able to: 1. Recognize high risk localized prostate cancer and its treatment options including surgery, radiation, and neoadjuvant systemic therapies. 2. Define the disease state known as BCG unresponsive bladder cancer and review the available FDA approved as well as clinical trial therapies in this space. 3. Describe the results of neoadjuvant chemotherapy for muscle invasive bladder cancer and elaborate on the role of systemic immunotherapy in this setting. FACULTY Christopher B. Anderson, MD, MPH Assistant Professor of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY Guarionex Joel Decastro, MD, MPH, Assistant Professor of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY James M. McKiernan, MD, John K. Lattimer Professor of Urology; Director, Urologic Oncology; Chair, Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY Catherine S. Spina, MD, PhD, Assistant Professor of Radiation Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY Mark N. Stein, MD, Associate Professor of Medical Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY AGENDA 5:00 PM Welcome James M. McKiernan, MD 5:05 PM High Risk Localized Prostate Cancer: Updates in Multidisciplinary Care Christopher B. Anderson, MD, MPH & Catherine S. Spina, MD, PhD 5:25 PM BCG Unresponsive High Risk Non-Muscle Invasive Bladder Cancer: An Expanding Menus of Options Guarionex Joel Decastro, MD, MPH 5:45 PM Muscle Invasive Bladder Cancer: It’s Not Just Cystectomy Anymore Mark N. Stein, MD 6:05 PM Q&A 6:30 PM Adjourn This activity has been approved for AMA PRA Category 1 Credit™

  • Contemporary Management of Neoplastic Diseases of the Oral Cavity

    Saturday, April 24, 2021
    11:00 AM to 2:00 PM
    TBD Zoom Meeting
    • College of Dental Medicine
    • College of Physicians and Surgeons
    In this session, attendees will hear from practitioners who treat patients with oral cancer. Over the course of the session, presenters will share best practices from Columbia’s multidisciplinary head and neck/oral cancers team to maximize treatment outcomes while sparing patients’ morbidity, as well as exciting new research in head and neck cancers on the horizon. Upon conclusion of this activity, participants will be better able to: · Describe types of oral cancer in patient populations · Discuss how present-day treatment improves cancer outcomes while preserving form and function · Recognize clinical lesions that are considered premalignant, such as leukoplakia and erythroplakia · Understand the role of tissue biopsy in everyday clinical practice and when/how to biopsy lesions · Recognize the varied clinical appearances of oral cancer · Develop sound treatment strategies and referral systems for management of patients with potentially cancerous oral lesions

  • WEBINAR: Lung Cancer

    Thursday, May 6, 2021
    5:00 PM to 6:30 PM
    ZOOM
    • College of Physicians and Surgeons
    Simon K. Cheng, MD, PhD, Residency Program Director and Assistant Professor of Radiation Oncology Naiyer A. Rizvi, MD, Professor of Medicine at CUMC Catherine A. Shu, MD, Professor of Medicine at CUMC Joshua R. Sonett, MD, Edward C. and Anne K. Weiskopf Professor of Surgical Oncology (in Surgery) at CUMC This activity has been approved for AMA PRA Category 1 Credit™

  • WEBINAR: Dementia

    Thursday, May 20, 2021
    5:00 PM to 6:30 PM
    ZOOM
    • College of Physicians and Surgeons
    The Division of Aging and Dementia and the Taub Institute for Alzheimer’s Disease and the Aging Brain have a strong tradition of offering state of the art clinical care for patients with neurodegenerative diseases paired with access to cutting edge observational studies and clinical trials designed to modify disease progression in symptomatic and at-risk individuals. Clinical Characterization (“Deep phenotyping”) of patients with Alzheimer’s Disease (AD), Dementia with Lewy Bodies (DLB) and Frontotemporal Dementia (FTD) combined with extensive biofluid banking has facilitated discoveries into the underlying biology of these diseases that we hope will translate into new individualized treatments based on genetic and lifestyle factors. At the conclusion of this activity, participants will be better able to: • Discuss the use of diagnostic biomarkers in dementia, including imaging, spinal fluid, and new blood-based biomarkers. • Advance understanding of the current knowledge on the genetics of early and late-onset Alzheimer’s Disease. • Evaluate the use of omics technologies in identifying biological mechanisms and potential therapeutic targets in Alzheimer’s Disease. • Describe the clinical spectrum, diagnostic approach and treatment strategies for Lewy Body Disorders. AGENDA Alzheimer Disease-Recent Advances in Diagnostic Biomarkers and Therapies Lawrence S. Honig, MD, PhD Advances in the genetics of early and late-onset Alzheimer’s Disease Christiane Reitz, MD, PhD A functional Genomic (multi-omics) approach to the understanding of Alzheimer’s Disease Badri N. Vardarajan, PhD, MS Lewy Body Disorders: Diagnosis and Therapeutic Approaches Karen S. Marder, MD, MPH Frontotemporal Dementia: Update on Diagnosis and Novel Treatments Edward D. Huey, MD Panel Discussion and Q&A Moderators: Richard P. Mayeux, MD, MSc & E. Sander Connolly Jr., MD, FACS This activity has been approved for AMA PRA Category 1 Credit™

  • VIRTUAL EVENT: Cognitive Remediation in Psychiatry

    Friday, June 4, 2021
    10:45 AM to 5:00 PM
    Online
    • College of Physicians and Surgeons
    People with psychiatric disorders may have cognitive impairments that affect their ability to function in daily life, and benefit from psychiatric interventions. Cognitive skills training directly targets impaired cognitive processes seen across a variety of psychiatric conditions and thereby seeks to improve behavioral functioning. This conference will provide a forum for academic researchers, clinicians, and students to learn about evidence-based cognitive interventions. Research symposia will spotlight novel treatment approaches and inform key issues pertinent to treatment implementation and effectiveness. A clinical workshop will provide expert guidance in translating evidence-based cognitive remediation approaches for virtual delivery. Upcon conclusion of the activity, participants will be better able to: 1. Identify cognitive deficits, motivation deficits that interact with cognitive deficits, and how both can be targeted in recovery-oriented treatments for people with psychiatric disorders 2. Identify integrative intervention approaches to improve cognitive health, mental health, and functional outcomes in people with psychiatric disorders 3. Summarize factors that impact engagement in cognitive treatments and potential strategies to facilitate motivation and cognitive learning 4. Describe challenges to implementing empirically based cognitive interventions in routine settings and approaches to overcome them 5. Summarize how to provide remote cognitive health care

  • Inaugural Annual Meeting: American Society of Ophthalmic Trauma

    Saturday, June 5, 2021
    10:00 AM to 3:30 PM
    TBD Zoom Meeting
    • College of Physicians and Surgeons
    Ophthalmic trauma is a leading cause of unilateral blindness in the United States with a devasting impact on both individuals and society. Currently, there is no dedicated conference to ophthalmic trauma in the United States, and the American Society of Ophthalmic Trauma, Annual Meeting fills a critical gap in education for medical students, residents, fellows and ophthalmologists of all subspecialties in both private and academic practices. At the conclusion of this activity, participants will be better able to: • Formulate an evidence-based approach to ophthalmic trauma management • Describe the up-to-date clinical diagnosis and treatment of ophthalmic trauma in open-globe injuries, anterior and posterior segment management of complications of open-globe injuries, diagnosis and management of orbital and adnexal injuries, and unique characteristics of pediatric ophthalmic injuries • Indicate the cutting-edge scientific discoveries in ophthalmic trauma management

  • 4th Annual Columbia University Endoscopic Otolaryngology Course

    Wednesday, June 9, 2021 to Friday, June 11, 2021
    10:00 AM to 1:30 PM
    ZOOM
    • College of Physicians and Surgeons
    We are excited to bring the 4th Annual Columbia University Endoscopic Otolaryngology Course to the surgery community worldwide, again in a virtual format! This fun and exciting course will introduce cutting-edge surgical techniques and the latest advances in patient care, including transcanal endoscopic ear surgery, transnasal Eustachian tube surgery, and advances in endoscopic sinus, skull base, and orbital surgery. This course is the first of its kind to feature dedicated endoscopic orbital surgery instruction!

  • VIRTUAL EVENT: The Columbia Renal Biopsy Course

    Saturday, June 26, 2021 to Friday, July 16, 2021
    All day
    Online
    • College of Physicians and Surgeons
    The course is designed to assist nephrologists and nephropathologists in diagnosing and managing the most common forms of medical renal disease, including diseases that target the glomerulus, tubules, interstitium and blood vessels. The activity will span three weeks and will include a combination of pre-recorded lectures and live sessions covering the following content areas: Week 1 (June 26, 2020): Nephrotic syndrome Week 2 (July 3, 2020): Nephritic syndromes Week 3 (July 10): Tubulointerstitial, Vascular, Dysproteinemia, & Transplant Each week will consist of approximately 8 hours of asynchronous content culminating in a 2 hour and 15-minute live session. The live sessions will be held on July 2, 9, and 16 and will consist of: • 45 minutes of Q&A/panel discussion with faculty focusing on the lectures for the week. • 45 minutes of 2 CPC cases, with pathologist and clinicians from Columbia University Irving Medical Center • 45 minutes of “show & tell” renal pathology lab – 7-10 cases per day Upon completion of this activity, participants will be better able to understand: • the pathophysiology and clinical aspects of the major parenchymal diseases of the kidney, with emphasis on clinical-pathologic correlations and the role of renal biopsy. • pathology, pathophysiology, pathogenesis, clinical presentation, prognosis, and optimal therapy for many different medical renal diseases, including but not limited to minimal change disease, FSGS, membranous nephropathy, amyloidosis, membranoproliferative glomerulonephritis, IgA nephropathy, hereditary nephritis, acute post-infectious glomerulonephritis, amyloidosis, light chain deposition disease, myeloma cast nephropathy, cryoglobulinemic glomerulonephritis, lupus nephritis, and diabetic nephropathy. This activity has been approved for AMA PRA Category 1 Credit™ CLICK HERE to view the full agenda

  • 2nd International Tremor Congress

    Wednesday, November 17, 2021 to Friday, November 19, 2021
    All day
    TBD Zoom Meeting
    • College of Physicians and Surgeons
    The Movement Disorders Division within the Department of Neurology of the Columbia University Vagelos College of Physicians and Surgeons will be conducting 2nd International Tremor Congress, a comprehensive meeting on advances in the diagnosis and management of tremor and also the science of tremor disorders. The meeting addresses an important need for a comprehensive, academic educational program providing the latest information on innovations, insights on the latest science, and translation of the science to patient care. The conference is also consistent with the national call of the Precision Medicine Initiative for health care providers to pursue new approaches that tailor treatment to the individual patient’s characteristics because patient response to conventional treatments for tremor is often variable; therefore, education on new surgical and medical advancements that account for individual differences can optimize outcomes for patients with tremor. In addition, to understand the heterogeneity of tremor disorders will help to design and conduct robust clinical trials to push forward therapy development. At the conclusion of this activity, participants will be better able to: • Formulate an evidence-based approach to optimize the treatment for tremor disorders. • Develop evidence-based scientific knowledge for the future clinical study design in tremor disorders. • Describe the up-do-date clinical diagnosis and treatment in each tremor disorder. • Indicate the cutting-edge scientific discovery for tremor and also current tremor therapy development.